Press Release Details

Quest Diagnostics to Speak at UBS Warburg Global Life Sciences Conference

10/07/2002

TETERBORO, N.J., Oct 7, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer and Surya N. Mohapatra, Ph.D., President and Chief Operating Officer, are scheduled to speak at the UBS Warburg Global Life Sciences Conference on Tuesday, October 8, 2002, at The Plaza Hotel, New York, New York. The Quest Diagnostics presentation is scheduled to begin at 10:00 a.m. Eastern Time.

Audio of the presentation will be presented live during the conference and will be available to investors on the UBS Warburg's site at: http://www.ubswarburg.com. Access to this site is public, and requires no password. The webcast will also be available on the Quest Diagnostics website at: http://www.questdiagnostics.com. In addition, the archived webcast will be available three hours after the actual presentation time and will be available until November 10, 2002.

Quest Diagnostics Incorporated is the nation's leading provider of diagnostic testing, information and services, providing insights that enable physicians, hospitals, managed care organizations and other healthcare professionals to make decisions to improve health. The company offers the broadest access to diagnostic laboratory services through its national network of laboratories and patient service centers. Quest Diagnostics is the leading provider of esoteric testing, including gene-based medical testing, and empowers healthcare organizations and clinicians with state-of-the-art connectivity solutions that improve practice management. Additional company information can be found on the Internet at: www.questdiagnostics.com.

The statements in this press release which are not historical facts or information may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome to be materially different. Certain of these risks and uncertainties are listed in the Quest Diagnostics Incorporated 2001 Form 10-K and subsequent filings.

SOURCE Quest Diagnostics Incorporated

CONTACT:
Investors, Laure Park, +1-201-393-5030, or Media, Gary Samuels,
+1-201-393-5700, both of Quest Diagnostics

URL: http://www.questdiagnostics.com

Copyright (C) 2002 PR Newswire. All rights reserved.